Emerald Mutual Fund Advisers Trust Gossamer Bio, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$7.21 - $14.88 $6.54 Million - $13.5 Million	-907,499 Reduced 54.62%	753,981 $9.03 Million
Q1 2022 Apr 29, 2022	SELL	$8.44 - $12.49 $1.21 Million - $1.8 Million	-143,825 Reduced 7.97%	1,661,480 $14.4 Million
Q4 2021 Feb 02, 2022	BUY	$10.12 - $14.07 $2.3 Million - $3.2 Million	227,558 Added 14.42%	1,805,305 $20.4 Million
Q3 2021 Oct 28, 2021	BUY	$7.25 - $13.23 $2.3 Million - $4.19 Million	316,667 Added 25.11%	1,577,747 $19.8 Million
Q2 2021 Jul 29, 2021	BUY	$8.0 - $9.75 $6.5 Million - $7.92 Million	812,728 Added 181.27%	1,261,080 $10.2 Million
Q1 2021 Apr 29, 2021	BUY	$8.63 - $10.94 $3.87 Million - $4.9 Million	448,352 New	448,352 $4.15 Million

109

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $84.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.